GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Beijing Strong Biotechnologies Inc (SZSE:300406) » Definitions » EV-to-FCF

Beijing Strong Biotechnologies (SZSE:300406) EV-to-FCF : 13.33 (As of Jul. 08, 2025)


View and export this data going back to 2014. Start your Free Trial

What is Beijing Strong Biotechnologies EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Beijing Strong Biotechnologies's Enterprise Value is ¥8,290 Mil. Beijing Strong Biotechnologies's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2025 was ¥622 Mil. Therefore, Beijing Strong Biotechnologies's EV-to-FCF for today is 13.33.

The historical rank and industry rank for Beijing Strong Biotechnologies's EV-to-FCF or its related term are showing as below:

SZSE:300406' s EV-to-FCF Range Over the Past 10 Years
Min: 12.91   Med: 41.94   Max: 193.89
Current: 13.31

During the past 13 years, the highest EV-to-FCF of Beijing Strong Biotechnologies was 193.89. The lowest was 12.91. And the median was 41.94.

SZSE:300406's EV-to-FCF is ranked better than
77.88% of 104 companies
in the Medical Diagnostics & Research industry
Industry Median: 24.645 vs SZSE:300406: 13.31

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2025-07-08), Beijing Strong Biotechnologies's stock price is ¥14.00. Beijing Strong Biotechnologies's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 was ¥0.830. Therefore, Beijing Strong Biotechnologies's PE Ratio (TTM) for today is 16.87.


Beijing Strong Biotechnologies EV-to-FCF Historical Data

The historical data trend for Beijing Strong Biotechnologies's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beijing Strong Biotechnologies EV-to-FCF Chart

Beijing Strong Biotechnologies Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 138.76 45.14 34.70 26.65 14.61

Beijing Strong Biotechnologies Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 26.37 17.59 17.02 14.61 14.97

Competitive Comparison of Beijing Strong Biotechnologies's EV-to-FCF

For the Diagnostics & Research subindustry, Beijing Strong Biotechnologies's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Beijing Strong Biotechnologies's EV-to-FCF Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Beijing Strong Biotechnologies's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Beijing Strong Biotechnologies's EV-to-FCF falls into.


;
;

Beijing Strong Biotechnologies EV-to-FCF Calculation

Beijing Strong Biotechnologies's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=8290.299/622.005
=13.33

Beijing Strong Biotechnologies's current Enterprise Value is ¥8,290 Mil.
Beijing Strong Biotechnologies's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥622 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Beijing Strong Biotechnologies  (SZSE:300406) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Beijing Strong Biotechnologies's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=14.00/0.830
=16.87

Beijing Strong Biotechnologies's share price for today is ¥14.00.
Beijing Strong Biotechnologies's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.830.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Beijing Strong Biotechnologies EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Beijing Strong Biotechnologies's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Beijing Strong Biotechnologies Business Description

Traded in Other Exchanges
N/A
Address
No. 15 Hua Yuan Dong Lu, 5th Floor, Kuang Yi Building, Haidian District, Beijing, CHN, 100191
Beijing Strong Biotechnologies Inc is a China-based provider of in-vitro (IVD) diagnostics products and service. The company is engaged in the research, development, production, and sale of IVD products. It also provides diversified clinical diagnosis solutions to customers. Its products include clinical biochemistry testing, coagulation testing, blood typing, serology and automated blood grouping analyzer. The firm has established a clinical biochemistry platform of the enzymatic method (including enzymatic cycling method), immunoturbidimetric method, and latex immunoturbidimetric method.
Executives
Shuang He Executives
Luo Ai Ping Director
Directors, executives
Liu Wei Executives
Zhou Ming Executives
Zhuang Xian Min Directors, executives
Zhang Yi Executives
Liu Xi Directors, executives
Sun Xiao Lin Director
Yu Jian Ping Executives

Beijing Strong Biotechnologies Headlines

No Headlines